Search Results - Kurilik, Gwen

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML

    The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML by O'Dwyer, Michael E., Mauro, Michael J., Kurilik, Gwen, Mori, Motomi, Balleisen, Suzanne, Olson, Susan, Magenis, Ellen, Capdeville, Renaud, Druker, Brian J.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

    Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate by O’Dwyer, Michael E., Mauro, Michael J., Blasdel, Carolyn, Farnsworth, Melanie, Kurilik, Gwen, Hsieh, Yi-Ching, Mori, Motomi, Druker, Brian J.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    BCR-ABL RNA Levels at the Time of a Complete Cytogenetic Response (CCR) Predict the Duration of CCR in Imatinib-Treated Chronic Myeloid Leukemia Patients

    BCR-ABL RNA Levels at the Time of a Complete Cytogenetic Response (CCR) Predict the Duration of CCR in Imatinib-Treated Chronic Myeloid Leukemia Patients by Press, Richard D., Love, Zac, Tronnes, Ashlie A., Kurilik, Gwen, Mauro, Michael J., Deininger, Michael W., Druker, Brian J.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: